ASCO Prostate Cancer Update Focuses on Central Trials of Triple Therapy
Updated ASCO guidelines for non-castrate, recurrent, advanced, or metastatic prostate cancer focus on data from the PEACE-1, ARASENS, ENZAMET and ARCHES trials. “The major reason fo...